chrisvoncsefalvay/vaers-outcomes huggingface dataset:
[Chest Pain ] This is a 20 year old female who received the 1st Pfizer dose on 5/17/21.  On 5/21/21 at 1723, the patient reported to our urgent care facility with a chief complaint of chest tightness (hurts when laying down), difficulty breathing, and nausea since the evening of 5/20/21. Given a recent Nexplanon insertion the day prior (5/20/21), the provider had a concern for possible PE so the patient was referred to the Emergency Department.  The patient arrived at the ED and was seen by the provider on 5/22/21 at 0416.  The patient continued to report chest discomfort as a heaviness, squeezing, ache.  The pain was constant and worse upon taking a deep breath.  Following a review of labs, EKG, Troponin, physical exam, the ED provider diagnoses 'chest wall pain' and the patient was discharged home with instructions to f/u as an outpatient for any ongoing symptoms.  No additional chart documentation as of this report date (5/25/21).
(Rt) arm swollen, warm to touch, 5 inch diameter knot at site. Didn't see MD, used ice packs  et took TYLENOL. Resolved x 1 wk.
Reporting pharmacy error in administration: We requested and were told that we were receiving and received the Pfizer Bivalent vaccine.  However, the next day, the pharmacy called to say they had given us the wrong vaccine.  They said they gave us Pfizer's old booster, not the updated bivalent booster.  They told us that we would now have to wait two more months before getting the bivalent booster.
feels a little dizzy; Noticed her voice is not quite right; feels kind of wierd; significant loss of hearing in right ear; when she eats fruit, she notices blocked feeling in her ear. When she talks she notices an echo in her ear; muscle pain in injection site the first night after her dose; Sore Arm Left; This is a spontaneous report from a contactable consumer (patient).   A 61-year-old female patient received first dose bnt162b2 (PFIZER COVID VACCINE), via an unspecified route of administration, administered in Arm Left on 20Mar2021 (Batch/Lot Number: ER2613) as single dose for COVID-19 immunization.  There were no medical history and concomitant medications.  The patient received first dose of PFIZER COVID VACCINE last Saturday 20Mar2021.  On 26Mar2021 the patient reported muscle pain in injection site the first night after her dose but it only lasted one day.  Today 26Mar2021 noticed significant loss of hearing in right ear and feels a little dizzy.  Noticed her voice was not quite right. She stated she felt kind of weird. When she eats fruit, she notices blocked feeling in her ear. When she talked she noticed an echo in her ear.  She stated she was typically healthy. had this been reported and wondering when it will go away. On 29Mar2021 she stated she called last Friday and reported it because she was so frightened that she had lost her hearing in her right ear. She stated that after one day, her hearing half recovered and after two days, her hearing completely recovered. The patient experienced hearing loss in right ear from 26Mar2021 and sore arm left from 20Mar2021. She stated that she was 61, almost 62 and was very healthy, no medications, not sick. She stated her last vaccine that she had was in childhood. She stated that she doesn't get the flu shot and doesn't get the flu, nothing really. She stated that she had this vaccine for other people, for their concern, she was not worried. She stated the first night, she felt muscle pain in her arm and then she forgot about the vaccine, until Friday. She stated she realized when she searched sudden loss of hearing. She stated that it was all gone. She stated she thought should she have the second one, She stated she thinks it was fine. Clarifies that the first morning she noticed it when she got up it was a little weird, She stated she couldn't hear something, so she started searching this and said she better check it out because it said she needed to get treated sooner. She stated she thought what should she do and was in a panic and that was how she went on the internet and make the link. She stated she wanted to let Pfizer know that everything was back to normal. The outcome of event 'significant loss of hearing in right ear' and 'when she eats fruit, she notices blocked feeling in her ear. When she talks she notices an echo in her ear' was recovered on 28Mar2021, of event 'muscle pain in injection site the first night after her dose' and 'Sore Arm Left' and was recovered on 21Mar2021, of other events was recovered on an unspecified date.
Awoken from sleep on 3/19 early in the morning.  Loss sense of smell on 3/19. Increased severity of diarrhea. No fever at all during 3/19 to report. Excessive fatigue 3/19-3/21. Somewhat reduced fatigue 3/22-3/23 increased fatigue on 3/24-3/27. The fatigue and coughing combined required time off from working even though my work is only on computer. I was falling also regularly during the days on 3/19-3/21 and 3/24-3/27.  Still not able to smell most foods.
insomnia 1st week of being vaccinated.  within a few seconds of vaccine got tremors dizzy and dehydration had to drink lots of water.  urine stunk for about a week.  husband and my pets could detect a different odor coming out of my body. dry chapped lips hyperactive energy  started about 2weeks after vaccine so far has lasted through July  2021 possibly ongoing on triggers such as the smoke from wildfires, controlled burns and burn season in the  area which have an impact on my lungs. about 2 weeks after 1st dose i lit a candle and my lungs felt as if there was a big fire nearby ive never had that reaction from lighting a candle before.  I was also two days  later sensitive to smoke nearby in the area had same reaction.   Abourt 4months after vaccine i somehow got a whif of distilled vinegar dont quite rmember how it happened but i must upon opening the vinegar and pouring some into a dish i got momentarily dizzy then  my nose became very mucuous the mucous pouring out my nose for a while like opening a faucet.  Ive never had that happen to me before. change in feces  almost diarhea  then about an hour later diarhea no more feces for the rest of the day.  onset is day after vaccine lasted about four months gradually started returning to normal.  bug bites-  in september  i got a bugbite and had felt my breathing restricted as in the bad wildfire smoke and had a pink ring on my skin around the bugbite.  this happened twice with bugbites outdoors.  ive never had that happen to me before.  sensation i felt in my head i had not ever felt before this was in July 2021.  I described what i felt motioning with myhands was told it was a blood sugar reaction
12 hours after second Pfizer vaccine dose - Fever, body pain , chest pressure,   24 hours.   Chest pressure and Dyspnea on exertion continues  June 1 - present day of June 14th Severe dizziness begins on June 12th
Information has been received from a physician concerning three patients who on an unspecified date, were vaccinated with a dose of VARIVAX (Merck) (Lot number not reported).  The patients developed an injection site reaction.  Subsequently, the patient's recovered.  There was no product quality complaint.  (Also refer to WAES # 0808USA04427).  Follow-up information has been received from a Licensed Practical Nurse, concerning an 8 year old female patient who was vaccinated with a dose of VARIVAX (Merck) (Lot # 660402/0271X).  The patient experienced red and swollen upper arm from injection site and had blisters around the injection site.  Additional information has been requested.
VERY TIRED; This spontaneous report received from a patient concerned a 95 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included skin cancer, neuropathy, and no-healing wound in leg. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-MAY-2021 for prophylactic vaccination. Concomitant medications included gabapentin for skin cancer. On 07-MAY-2021, the subject experienced very tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of very tired was not reported. This report was non-serious.
shortly p/vax 3FEB pt started w/s/s red inflamed around inj site, vomiting, fever spiked to 12;MD rx APAP;
Starting about 12 hours after the shot I got chills a high fever, all over body aches and began vomiting. I vomited repeatedly for about 6 hours and could not even keep water down. I was concerned that I might have to go to the emergency room. The following morning I felt a bit better. No longer nauseous, just mild body aches, headache and fatigue. By 48 hours all symptoms were gone.
pt received dose 1 of pfizer/biontech covid-19 vaccine on 12/29/20 at approx 14:04.  after 10 minutes of observation pt developed a left upper trunk rash.  patient's HR was elevated and BP elevated.  pt was nervous.  Benadryl 25 mg PO and Pepcid 20 mg PO was given and patient had no other reactions.  after 30 additional minutes of observation, pt was able to go home as spouse was driving her home
Guillain Barre Syndrome. Initially with left facial weakness, then paresthesias and distal weakness in arms and legs. Some cerebellar ataxia.
First 3 days, Left arm Hurt. That has gone away. Second week through presently, Pain in back of neck on left side, running down along left shoulder blade. Beginning third week, feeling dizzy and week, loss of appetite, dark / black color stool. Beginning 9/3/2021 stomach growling and diarrhea.
pt rcvd vax & suffered fever, vomiting, diarrhea & lack of appetite; WBC: 19500
On 03/05, injection at 10:13a.  At about 8:00p both hands started to itch and at 9:30p they started to burn. Also, that evening was nauseous and very tired, took Benadryl and went to bed.  Awoke on 03/06 at 7:30a with face stinging, left arm aching and hands still burning.  Upon reviewing in mirror, the face, chest, arms and legs were pink/red and burning/stinging such as a sun burn feels.  Continued with the Benadryl.  At about 8:30a a headache started and ended after about an hour.  At 9:30a called Dr office & spoke with a rep from urgent care.  Temp 96.7.  They instructed to use cool compresses on face and chest, can take Benadryl and ibuprofen.  If symptoms are longer than 3 days call back.  Continued with Benadryl throughout the day.  On 03/07 awoke with all burning symptoms the same.  At bed time took Benadryl again.  On 03/08 awoke with all burning symptoms the same.  At 9:20a tongue felt awkward/numbness.  Called PCP, instructed to call Allergist.   At 10:10a call Allergist and the scheduled an appointment for me for 3/9.  At 11:55a wen to ER at hospital.  The injected prednisone, pepcid and Benadryl and did bloodwork.  Throat and tongue began to ease.  Bloodwork results showed increased inflammation and white blood cell count was normal.  Released at 4:45p with prescriptions for prednisone and pepcid for 3 days and instructed to continue with Benadryl.  On 3/9 awoke with same burning symptoms.  Met with Dr. (allergist) and he instructed to continue taking what the hospital prescribed.  He informed for me to get the 2nd vaccine and provided a prescription for Prednisone (5 days) and to be get OTC Pepcid and Zyrtec.  He said to take 2 Zyrtec 2 hours prior to the 2nd vaccine and to take the prednisone and pepcid as needed.  On 3/10 and 3/11 awoke with same symptoms of burning skin.  While taking the Benadryl, the painfulness of stinging/tightness of skin eases slightly, but does not resolve, the skin still burns.  Without the Benadryl, it feels like I will become blistered.
Rash at injection site; received the first dose of Shingrix via subcutaneous route; This case was reported by a nurse via call center representative and described the occurrence of injection site rash in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. Nurse reported that 17 patients received the first dose of Shingrix via subcutaneous route, which led to intramuscular formulation administered by other route. Some of them were female patients. Nurse did not provide initials, date of birth, lot number and expiration dates of the vaccines. She did not said how many patients were male and how many were female. This is 1 of the 17 cases, reported by same reporter.   Follow up information received from the nurse on 3rd April 2020: The patient's demographic details were updated. Concurrent medical conditions included coronary artery disease (CAD since 30th April 2015), mixed hyperlipidemia (since 30th April 2015), osteoarthritis (since 2015), degenerative joint disease (since 2018) and hypertension (since 30th April 2015).  On an unknown date, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was recovered/resolved. The reporter considered the injection site rash to be unrelated to Shingrix. The VAERS details were updated.
Nausea and vomiting; Nausea and vomiting; headache; muscle aches; fever; chills; joint pain; soreness at injection site; fatigue; This is a spontaneous report from a contactable nurse.   A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in right arm on 12Feb2021 (Lot Number: EL1283) as single dose for covid-19 immunization.  The patient medical history was not reported. Concomitant medications included colecalciferol (VITAMIN D) taken for an unspecified indication, start and stop date were not reported; ibuprofen (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported.  The patient previously took ciprofloxacin hydrochloride monohydrate (CIPRO) and experienced allergy, BNT162B2  (Lot number EM9810) on 19Jan2021 for covid-19 immunization, hepatitis a vaccine for immunization on 04Jan2021.  On 13Feb2021, at 03:00, the  patient experienced nausea and vomiting; headache; muscle aches; fever; chills; joint pain; soreness at injection site; fatigue. No COVID test was completed post vaccination. The outcome of events was not recovered.
Patient states he had an episode of syncope few hors after receiving vaccine. Patient presented to our urgent care with palpitations and was found to have Atrial fibrillation with RVR.
After beng given a Hep A vaccination and the Tetanus Shot patient had a grand mal seizure. Has been very tired post seizure but no other symptoms. 9/21/09 Spoke with reporter, no treatment sought, pt not seen at any facility nor any MDs. Pt does not have insurance. Case closed
Right thigh swelling and redness 24 hrs after DTaP immunization. Also very tender with itching.
Patient started to have SOB and vomiting on 9-12-17 at 7:00pm. She had received Varicella around 11:00am on 9-12-17 and Hepatitis A vaccine on 9-11-17.
Transverse myelitis maximal at C3-C4 on the right side but extending down as far as T1.  He has weakness in his right arm much more than his leg on the right side.  Also drags the right leg somewhat when he walks.  Minimal sensory symptoms in the right arm.  Work-up negative for multiple sclerosis negative MRI of the brain or thoracic spinal cord.  CSF negative for oligoclonal bands or IgG synthetic rate therefore negative for MS.  Aquaporin-4 level in CSF was negative.  Collagen-vascular work-up negative except for a positive ANA.  Somewhat responsive to high-dose corticosteroids.
Patient went to the ER Tuesday night after receiving 2nd Moderna COVID-19 vaccination. He was diagnosed with a pulmonary embolism. Doctors could not say if it was directly related to the vaccination, but did occur later in the day after receiving the second dose of his vaccines. Patient has since been discharged on 8/27 on blood thinners. Patient was experiencing chest pain and blood in sputum for 2 weeks prior to receiving second dose (2 weeks after 1st dose had  been administered)
Information has been received from a 68 year old female consumer with penicillin and erythromycin allergy who in December 2008, was vaccinated with the first dose of ZOSTAVAX (Merck) (lot not reported). Concomitant therapy included ezetimie (MSD) and simvastatin (MSD). On 18-MAR-2009 the patient broke out with a case of shingles. The patient sought unspecified medical attention. As of 20-MAR-2009, the patient symptoms persisted. No further information is available.
Patient?s PCP Dr. gave me a list of vaccines that the patient needed to get up to date with his vaccination. I was given two list the other list was for patient?s brother who was also being seen. The list of vaccines were Dtap, IPV and Hep A, the patient?s brother had a similar list, the brothers list was Dtap, IPV and MMRV.  I went to the vaccines room and got the vaccines ready, without double checking I had one of the other MA assist me with giving the immunization shots to the patients.  I gave the vaccine shots Dtap/IPV combo and MMRV to the patient?s brother first it went well and MA gave the vaccine shots Dtap/IPV and Hep A to the patient and injections went well too, injections were tolerated well.  I documeted the injections I gave in patient?s brother?s record and MA was documenting the vaccines shots her gave and brought to by attention that the combo was for 4 year old and up and we did not have the combo for the patient?s age range in Dtap/IPV combo, we did have the vaccines available separately which we could have given but I was thinking, ?combo?, ?less sticks? and I did not double check the age range.
Injection site pruritis; Injection site swelling; Injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site pruritis), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE ERYTHEMA (Injection site red) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Injection site pruritis), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE ERYTHEMA (Injection site red). At the time of the report, VACCINATION SITE PRURITUS (Injection site pruritis), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Irriation, swelling and warmth at injection site has lasted ~72 hours. Patient was seen by PCP and was given antibiotic for celulitis.
Tonic seizure x 2, each lasting about 60 seconds, no fever but accompanied by headache with postictal phase of about 45 minutes.
the male patient received the MMR and Varivax immunizations IM not SQ; This spontaneous report was received from an other health professional and refers to an adult male patient of unknown age (reported as between 30-40 years old). The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not provided.  On 30-SEP-2020, the patient was vaccinated with a doses of: measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status: recombinant Human albumin (rHA)) (M-M-R II) lot # S005251, expiration date 20-FEB-2021 and varicella virus vaccine live (oka/merck)(VARIVAX) lot # S024364, expiration date 06-AUG-2021 both for prophylaxis (exact doses, doses # and anatomical locations were not provided). Both vaccines were administered intramuscularly (IM) instead of subcutaneously (SQ). It was reported, that the patient was not aware of the incorrect route of administration. The reported asked for some information about giving these vaccines IM instead of SQ.
This spontaneous report was received from a medical assistant refers to a 15 month old female patient. The patient's concurrent conditions, medical history, drug reactions and allergies were not reported. The patient's concomitant medication included Diluent Mrk Inj. on 26-JAN-2018, the patient was vaccinated with M-M-R II (dose, units and frequency not reported) (lot# and expiration date unknown) subcutaneously and VARIVAX (dose, units and frequency not reported) (lot number and expiration date unknown) subcutaneously. On 18-APR-2018, the patient was vaccinated with M-M-R II (dose, units and frequency not reported) (lot# N013295 and expiration date: 28-APR-2019) subcutaneously and VARIVAX (dose, units and frequency not reported) (lot number N030406 and expiration date: 30-OCT-2019) subcutaneously. Patient had received second dose of M-M-R II and VARIVAX on 18-APR-2018, which was less than 3 months from previously administered dose of each vaccine on 26-JAN-2018 (inappropriate schedule of drug administration). No adverse effects reported. No product quality complaint was involved. Lot number [N013295] has been verified to be a valid lot number for M-M-R II.
10-8-07 sore, scratchy throat. 10-9-07 3:00 pm fever 103, chills, myalgia, confusion.  11/26/2007 MR received for DOS 10/09-11/2007 with D/C DX Adverse reaction to influenza vaccine.  Pt presented to ER on 10/9/07 with fever and mental status changes/delirium, numbness of feet.  Txd with abx with resolution of fever.
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to an 11-year-old female patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 15-NOV-2022, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.
Vomiting; sips of water and hot apple/cinnamon tea; felt better 11 p.m. on April 3, 2021.